GB2456904B8 - Stable neurotensin receptor mutants - Google Patents

Stable neurotensin receptor mutants

Info

Publication number
GB2456904B8
GB2456904B8 GB0901109A GB0901109A GB2456904B8 GB 2456904 B8 GB2456904 B8 GB 2456904B8 GB 0901109 A GB0901109 A GB 0901109A GB 0901109 A GB0901109 A GB 0901109A GB 2456904 B8 GB2456904 B8 GB 2456904B8
Authority
GB
United Kingdom
Prior art keywords
neurotensin receptor
receptor mutants
stable
stable neurotensin
mutants
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
GB0901109A
Other versions
GB0901109D0 (en
GB2456904A (en
GB2456904B (en
Inventor
Antony Johannes Warne
Christopher Gordon Tate
Francesca Magnani
Malcolm Peter Weir
Maria Josefa Serrano-Vega
Richard Henderson
Yoko Shibati
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nxera Pharma UK Ltd
Original Assignee
Heptares Therapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0705450A external-priority patent/GB0705450D0/en
Priority claimed from GB0724052A external-priority patent/GB0724052D0/en
Application filed by Heptares Therapeutics Ltd filed Critical Heptares Therapeutics Ltd
Priority to GB0805267A priority Critical patent/GB2447786C/en
Priority claimed from GB0805267A external-priority patent/GB2447786C/en
Publication of GB0901109D0 publication Critical patent/GB0901109D0/en
Publication of GB2456904A publication Critical patent/GB2456904A/en
Application granted granted Critical
Publication of GB2456904B publication Critical patent/GB2456904B/en
Publication of GB2456904B8 publication Critical patent/GB2456904B8/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72Receptors; Cell surface antigens; Cell surface determinants for hormones
    • C07K14/723G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH receptor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034Isolating an individual clone by screening libraries
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/566Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/72Assays involving receptors, cell surface antigens or cell surface determinants for hormones
    • G01N2333/726G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00Screening for compounds of potential therapeutic value
    • G01N2500/04Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Physics & Mathematics (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Plant Pathology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Peptides Or Proteins (AREA)
GB0901109A 2007-03-22 2008-03-20 Stable neurotensin receptor mutants Active GB2456904B8 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB0805267A GB2447786C (en) 2007-03-22 2008-03-20 Mutant G-protein coupled receptor proteins and methods for selecting them

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0705450A GB0705450D0 (en) 2007-03-22 2007-03-22 Mutant proteins and method for selecting them
GB0724052A GB0724052D0 (en) 2007-12-08 2007-12-08 Mutant proteins and methods for selecting them
GB0805267A GB2447786C (en) 2007-03-22 2008-03-20 Mutant G-protein coupled receptor proteins and methods for selecting them

Publications (4)

Publication Number Publication Date
GB0901109D0 GB0901109D0 (en) 2009-03-11
GB2456904A GB2456904A (en) 2009-08-05
GB2456904B GB2456904B (en) 2009-10-28
GB2456904B8 true GB2456904B8 (en) 2009-12-09

Family

ID=40846048

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0901109A Active GB2456904B8 (en) 2007-03-22 2008-03-20 Stable neurotensin receptor mutants

Country Status (1)

Country Link
GB (1) GB2456904B8 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2015209063C1 (en) 2014-01-27 2020-06-25 Molecular Templates, Inc. MHC class I epitope delivering polypeptides

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6420137B1 (en) * 1998-11-25 2002-07-16 American Home Products Corporation Nucleic acid encoding human neurotensin subtype 2 receptor

Also Published As

Publication number Publication date
GB0901109D0 (en) 2009-03-11
GB2456904A (en) 2009-08-05
GB2456904B (en) 2009-10-28

Similar Documents

Publication Publication Date Title
HK1258801A1 (en) Stabilized sulforaphane
EP2151236A4 (en) G-protein-conjugated receptor agonist
HK1159717A1 (en) Hinge
IL200845A0 (en) Oligomer-opoid agonist conjugates
GB2448067B (en) Sliding member
GB2463219B (en) Fixing
GB0718708D0 (en) Improved fitting
EP2163557A4 (en) Function-selective vitamin d receptor agonist
EP2379762A4 (en) Cermet
GB2456904B (en) Stable neurotensin receptor mutants
EP2154259A4 (en) Cermet
GB2452302B (en) Fixing
GB2448662B (en) Sliding member
GB0806180D0 (en) Improved structure
KG1098C1 (en) Towel-drying construction
TWI318555B (en) Fixing structure
GB0608516D0 (en) Receptor
GB0604684D0 (en) Receptor
GB0623853D0 (en) Receptor
GB0623399D0 (en) Receptor
TWI347822B (en) Hinge
TWI349511B (en) Hinge
GB0711971D0 (en) Middle mate
ZA200905054B (en) Construction set
AU318641S (en) Structural member

Legal Events

Date Code Title Description
732E Amendments to the register in respect of changes of name or changes affecting rights (sect. 32/1977)

Free format text: REGISTERED BETWEEN 20090924 AND 20090930